Yahoo
NasdaqGM - Nasdaq Real Time Price USD

CorMedix Inc. (CRMD)

5.32 +0.09 (+1.72%)
At close: November 6 at 4:00:01 PM EST
5.35 +0.03 (+0.56%)
After hours: November 6 at 7:54:28 PM EST
Trade CRMD on Coinbase

News headlines

Updated 38m ago
Powered by Yahoo Scout

CorMedix enters its November 12 earnings report with reaffirmed 2026 revenue guidance and approximately $355 million in cash. The key investor debate centers on DefenCath reimbursement levels in 2027, while REZZAYO’s potential expansion offers a separate growth catalyst.

Mobilize your Website
View Site in Mobile | Classic
Share by: